Home

bilge İnanılmaz rehin d serine schizophrenia kuğu kalıcı Kat

Research Breakdown on D-Serine - Examine
Research Breakdown on D-Serine - Examine

The therapeutic effects and possible underlying mechanisms of D-amino... |  Download Scientific Diagram
The therapeutic effects and possible underlying mechanisms of D-amino... | Download Scientific Diagram

Pharmacotherapy of cognitive deficits in schizophrenia | CNS Spectrums |  Cambridge Core
Pharmacotherapy of cognitive deficits in schizophrenia | CNS Spectrums | Cambridge Core

Diseases | Free Full-Text | D-Amino Acids as a Biomarker in Schizophrenia
Diseases | Free Full-Text | D-Amino Acids as a Biomarker in Schizophrenia

PDF] The involvement of the NMDA receptor d-serine/glycine site in the  pathophysiology and treatment of schizophrenia | Semantic Scholar
PDF] The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia | Semantic Scholar

D-serine for the treatment of negative symptoms in individuals at clinical  high risk of schizophrenia: a pilot, double-blind, placebo-controlled,  randomised parallel group mechanistic proof-of-concept trial - The Lancet  Psychiatry
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial - The Lancet Psychiatry

Glutamate hypothesis in schizophrenia - Uno - 2019 - Psychiatry and  Clinical Neurosciences - Wiley Online Library
Glutamate hypothesis in schizophrenia - Uno - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library

d‐Amino acids in the brain: d‐serine in neurotransmission and  neurodegeneration - Wolosker - 2008 - The FEBS Journal - Wiley Online  Library
d‐Amino acids in the brain: d‐serine in neurotransmission and neurodegeneration - Wolosker - 2008 - The FEBS Journal - Wiley Online Library

Therapeutic potential and underlying mechanism of sarcosine  (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction  models of schizophrenia - Ju-Chun Pei, Wei-Li Hung, Bei-Xuan Lin, Min-Han  Shih, Liang-Yin Lu, Da-Zhong Luo, Hwan-Ching ...
Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia - Ju-Chun Pei, Wei-Li Hung, Bei-Xuan Lin, Min-Han Shih, Liang-Yin Lu, Da-Zhong Luo, Hwan-Ching ...

Diseases | Free Full-Text | D-Amino Acids as a Biomarker in Schizophrenia
Diseases | Free Full-Text | D-Amino Acids as a Biomarker in Schizophrenia

D-serine in physiological and pathological brain aging
D-serine in physiological and pathological brain aging

D-Serine in Neuropsychiatric Disorders: New Advances
D-Serine in Neuropsychiatric Disorders: New Advances

Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral  Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE
Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE

Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like  behavior via D-serine depletion | Molecular Psychiatry
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion | Molecular Psychiatry

Clinical and biochemical study of D-serine metabolism among schizophre | NDT
Clinical and biochemical study of D-serine metabolism among schizophre | NDT

Multiple risk pathways for schizophrenia converge in serine racemase  knockout mice, a mouse model of NMDA receptor hypofunction | PNAS
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction | PNAS

Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous  Coagonists: Cell
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists: Cell

D-serine | C3H7NO3 - PubChem
D-serine | C3H7NO3 - PubChem

The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine,  glycine, and beyond. | Semantic Scholar
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. | Semantic Scholar

Frontiers | D-Serine: Potential Therapeutic Agent and/or Biomarker in  Schizophrenia and Depression?
Frontiers | D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?

Contributions of the d-serine pathway to schizophrenia - ScienceDirect
Contributions of the d-serine pathway to schizophrenia - ScienceDirect

Cell-type specific mechanisms of D-serine uptake and release in the brain.  - Abstract - Europe PMC
Cell-type specific mechanisms of D-serine uptake and release in the brain. - Abstract - Europe PMC

Frontiers | D-serine as a gliotransmitter and its roles in brain  development and disease
Frontiers | D-serine as a gliotransmitter and its roles in brain development and disease

Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral  Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE
Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE

Frontiers | The role of D-serine as co-agonist of NMDA receptors in the  nucleus accumbens: relevance to cocaine addiction
Frontiers | The role of D-serine as co-agonist of NMDA receptors in the nucleus accumbens: relevance to cocaine addiction